News Focus
News Focus
icon url

thesuicidekinginvest

11/03/11 11:10 PM

#1971 RE: ghmm #1970

I'm interested in Roche changeover rate from I.V. Herceptin to SC Herceptin, and same for Baxter to HyQ.

Both Roth Capital and Brean Murray analysts are bullish on a fast changeover to SC Herceptin in EU, if approved
icon url

ghmm

02/09/12 4:16 PM

#2016 RE: ghmm #1970

Unfortunately I think this speaks to the lack of interest in their Insulin program

http://www.sec.gov/Archives/edgar/data/1159036/000119312512049207/0001193125-12-049207-index.htm